Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 4/20 | 0.39 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.39 |
| ▸ | CDK2 | P24941 | 2/20 | 0.39 |
| ▸ | CDK9 | P50750 | 2/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | BTK | Q06187 | 1/20 | 0.36 |
| ▸ | MAP3K7 | O43318 | 3/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.36 |
| ▸ | EGFR | P00533 | 3/20 | 0.35 |
| ▸ | MET | P08581 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL29536657 | 1.00 | SCN9A (0.39) | SCN9ACCNT1CCNE1CDK2CDK9 | |
| Formic Acid SCHEMBL25423226 | 0.92 | MAPK8 (0.38) | SCN9ACCNT1CCNE1CDK2CDK9 | |
| Formic Acid SCHEMBL29537715 | 0.92 | MAPK8 (0.38) | SCN9ACCNT1CCNE1CDK2CDK9 | |
| Formic Acid SCHEMBL30595851 | 0.86 | EGFR (0.48) | BTKEGFR | |
| SCHEMBL30595879 | 0.84 | SYK (0.44) | SCN9ACCNT1CCNE1CDK2CDK9 | |
| SCHEMBL26075403 | 0.84 | SYK (0.44) | SCN9ACCNT1CCNE1CDK2CDK9 | |
| SCHEMBL26074894 | 0.84 | EGFR (0.50) | BTKEGFR | |
| SCHEMBL30590720 | 0.84 | EGFR (0.50) | BTKEGFR | |
| Formic Acid SCHEMBL30595871 | 0.82 | EGFR (0.43) | CDK2BTKEGFR | |
| SCHEMBL25421662 | 0.80 | MET (0.45) | CCNT1CCNE1CDK2CDK9EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4192582-A1 | KINASE INHIBITORS AND USES THEREOF | ABM Therapeutics Corporation (US) | 2023-06-14 | — | — | EP | disclosed |